Heat Biologics Principal Investigator Selected to Deliver Oral Presentation of New HS-110 Interim Phase 2 Data at the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium Jan 8, 2019
Heat Biologics to Participate in Panel Presentation at the Goldman Sachs Asia Pacific Healthcare Forum Nov 26, 2018
Heat Biologics CEO to Participate in Panel Presentation at The Cellular ''Living Drug'' Revolution Summit in New York City Oct 19, 2018